Drug Profile
Research programme: somatropin sustained-release - Critical Pharmaceuticals
Alternative Names: CP 016; hGH Depot -Critical Pharmaceuticals; SR somatropin - Critical Pharmaceuticals; sustained-release somatropin - Critical PharmaceuticalsLatest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Critical Pharmaceuticals
- Class Growth hormones
- Mechanism of Action Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Somatotropin deficiency
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Somatotropin-deficiency in United Kingdom (SC, Injection)
- 21 Nov 2013 Preclinical development for Somatotropin deficiency is ongoing in the United Kingdom
- 06 Oct 2008 Preclinical trials in Somatotropin deficiency in United Kingdom (SC)